GSK (GSK) P/S (1999 - 2026)
GSK (GSK) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM GSK (GSK) P/S is 2.31. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of GSK (GSK)
| Year | P/S | Change |
|---|---|---|
| 2026 | 2.31 | +101.75% |
| 2025 | 1.14 | -34.56% |
| 2024 | 1.75 | -16.43% |
| 2023 | 2.09 | +15.06% |
| 2022 | 1.82 | -35.08% |
| 2021 | 2.80 | +32.35% |
| 2020 | 2.12 | -22.46% |
| 2019 | 2.73 | +16.97% |
| 2018 | 2.33 | +2.70% |
| 2017 | 2.27 | -11.67% |
| 2016 | 2.57 | -4.87% |
| 2015 | 2.70 | -1.96% |
| 2014 | 2.76 | -11.32% |
| 2013 | 3.11 | +23.36% |
| 2012 | 2.52 | -4.66% |
| 2011 | 2.64 | +15.60% |
| 2010 | 2.29 | -4.53% |
| 2009 | 2.40 | +9.69% |
| 2008 | 2.18 | -34.94% |
| 2007 | 3.36 | -0.63% |
| 2006 | 3.38 | +16.08% |
| 2005 | 2.91 | +6.52% |
| 2004 | 2.73 | +1.65% |
| 2003 | 2.69 | +24.45% |
| 2002 | 2.16 | -24.81% |
| 2001 | 2.87 | -11.04% |
| 2000 | 3.23 | +0.21% |
| 1999 | 3.22 | N/A |
Comparison GSK (GSK) P/S with competitors
GSK (GSK) P/S is 2.31.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -75.10% |
| NVO | Novo Nordisk | 0.66 | -71.33% |
| GRFS | Grifols SA | 0.67 | -70.94% |
| AMRN | Amarin Corp | 1.39 | -39.80% |
| SCLX | Scilex Holding Company | 1.92 | -17.06% |
| SNY | Sanofi | 2.18 | -5.45% |
| PFE | Pfizer Inc | 2.18 | -5.45% |
| BMY | Bristol-Myers Squibb Company | 2.40 | +3.91% |
| BIIB | Biogen Inc | 2.93 | +26.91% |
| MRK | Merck & Co Inc | 4.54 | +96.46% |
| AZN | Astrazeneca plc | 4.58 | +98.59% |
| NVS | Novartis AG | 5.07 | +119.59% |
| AMGN | AMGEN Inc | 5.15 | +123.06% |
| GILD | Gilead Sciences Inc | 5.43 | +135.19% |
| JNJ | Johnson & Johnson | 6.34 | +174.60% |
| ABBV | Abbvie Inc | 7.15 | +209.68% |
| LLY | Lilly(Eli) & Company | 14.28 | +518.50% |